Fred Aslan, CEO: Artiva Biotherapeutics ARTV Planned sale · Filed 05/18

Trade details

Type: Planned sale notice
Stock: Artiva Biotherapeutics ARTV
Person: Fred AslanCEO
Planned sale date: 26/05/18
Filed: 26/05/18

$258.2K to be sold

Artiva Biotherapeutics trades, last 26 weeks

What else happened in Artiva Biotherapeutics around then

Filed or reported within 30 days of the trade day · 04/18~06/17

Fred Aslan's recent trades

Fred AslanCEO
Planned sale10b5-1 planArtiva Biotherapeutics
Planned sale10b5-1 plan
Artiva Biotherapeutics
ARTV
$262.2K
23,429 sh
$262.2K
Filed 09/08
Traded 09/08
Fred AslanCEO
SellArtiva Biotherapeutics
Sell
Artiva Biotherapeutics
ARTV
$244.3K
27,116 sh
$244.3K
Filed 05/19
Traded 05/19
Fred AslanPresident and CEO
Sell10b5-1 planArtiva Biotherapeutics
Sell10b5-1 plan
Artiva Biotherapeutics
ARTV
$19.1K
3,187 sh
$19.1K
Filed 25/12/15
Traded 25/12/15
Fred AslanCEO
Planned sale10b5-1 planArtiva Biotherapeutics
Planned sale10b5-1 plan
Artiva Biotherapeutics
ARTV
$42.1K
12,749 sh
$42.1K
Filed 25/12/15
Traded 25/12/15
Fred AslanPresident and CEO
Sell10b5-1 planArtiva Biotherapeutics
Sell10b5-1 plan
Artiva Biotherapeutics
ARTV
$21.5K
6,375 sh
$21.5K
Filed 25/11/17
Traded 25/11/17

Fred Aslan, CEO — plans to sell 28,000 sh of Artiva Biotherapeutics ARTV · $258.2K · around 05/18 | Whalegun